FDA.reportPublic FDA data

deflazacort 6 MG Oral Tablet [Emflaza]

RxCUI
1870950
RxNorm name
deflazacort 6 MG Oral Tablet [Emflaza]
Display name
deflazacort 6 MG Oral Tablet [Emflaza]
Full name
deflazacort 6 MG Oral Tablet [Emflaza]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
31b347d2-f156-4055-9d8f-7cf0df420296Emflaza 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [Emflaza] [SBD] · Emflaza 6 MG Oral Tablet [SY]321These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 201720251113